<SEC-DOCUMENT>0000950103-21-015270-index.html : 20211001
<SEC-HEADER>0000950103-21-015270.hdr.sgml : 20211001
<ACCEPTANCE-DATETIME>20211001175026
ACCESSION NUMBER:		0000950103-21-015270
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20211001
FILED AS OF DATE:		20211001
DATE AS OF CHANGE:		20211001

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Gline Matthew
		CENTRAL INDEX KEY:			0001750094

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40782
		FILM NUMBER:		211300244

	MAIL ADDRESS:	
		STREET 1:		C/O UROVANT SCIENCES, INC.
		STREET 2:		5151 CALIFORNIA AVENUE, SUITE 250
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92617

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Roivant Sciences Ltd.
		CENTRAL INDEX KEY:			0001635088
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				981173944
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			0331

	BUSINESS ADDRESS:	
		STREET 1:		CLARENDON HOUSE, 2 CHURCH STREET
		CITY:			HAMILTON HM11
		STATE:			D0
		ZIP:			HM11
		BUSINESS PHONE:		441-295-5950

	MAIL ADDRESS:	
		STREET 1:		CLARENDON HOUSE
		STREET 2:		2 CHURCH STREET
		CITY:			HAMILTON
		STATE:			D0
		ZIP:			HM11
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>dp159024_3-gline.xml
<TEXT>
Document 1 - file: dp159024_3-gline.html

Document 1 - RAW XML: dp159024_3-gline.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>dp159024_ex24.htm
<DESCRIPTION>EXHIBIT 24
<TEXT>
Document 2 - file: dp159024_ex24.htm

</DOCUMENT>
</SEC-DOCUMENT>